CA-Lu-177-PSMA

Radiopharmaceutical Precursor Solution

Used for the treatment of prostate cancer and neuroendocrine tumors.

CONTENT

Radiopharmaceutical Precursor Solution containing Lutetium (177Lu) Chloride and hydrochloric acid and water as excipients.

DEFINITION

Radiopharmaceutical precursor. Not directly administered to the patient. This medicinal product is used only for labeling molecules suitable for labeling with Lu-177 radionuclide.

CALIBRATION ACTIVITIES

Guaranteed calibrated delivery every day of the week